Glucotrack (GCTK) Net Income towards Common Stockholders (2010 - 2025)
Glucotrack (GCTK) posted Net Income towards Common Stockholders of -$3.4 million for Q4 2025, up 21.37% on a QoQ basis from -$4.3 million in Q3 2025, and up 11.86% year-over-year from -$3.1 million in Q4 2024.
Glucotrack (GCTK) Net Income towards Common Stockholders (2010 - 2025) Analysis & Trends
Glucotrack's Net Income towards Common Stockholders history runs 15 years deep, the most recent figure standing at -$3.4 million for Q4 2025.
- Quarterly Net Income towards Common Stockholders rose 11.86% year-over-year to -$3.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$16.1 million (down 9.47% YoY) and the FY2025 annual result came in at -$16.1 million, down 10.47% from the prior year.
- Net Income towards Common Stockholders was -$3.4 million for Q4 2025 at Glucotrack, up from -$4.3 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $2.4 million in Q4 2023 and bottomed at -$4.9 million in Q2 2025.
- A 5-year average of -$1.4 million and a median of -$1.2 million in 2022 frame the typical range for Net Income towards Common Stockholders.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders soared 214.88% — and 2024, when it sank 325.06%.
- Glucotrack's Net Income towards Common Stockholders stood at -$1.5 million in 2021, then jumped by 183.14% to $1.3 million in 2022, then surged by 87.41% to $2.4 million in 2023, then sank by 260.82% to -$3.9 million in 2024, then climbed by 11.86% to -$3.4 million in 2025.
- Business Quant data shows GCTK's Net Income towards Common Stockholders at -$3.4 million in Q4 2025, -$4.3 million in Q3 2025, and -$4.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 22.13 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | 13.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Glucotrack | 186,390.31 | -7.20 Mn | - | -3.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.42 Mn |
| Sep 30, 2025 | -4.35 Mn |
| Jun 30, 2025 | -4.87 Mn |
| Mar 31, 2025 | -3.50 Mn |
| Dec 31, 2024 | -3.88 Mn |
| Sep 30, 2024 | -3.26 Mn |
| Jun 30, 2024 | -4.57 Mn |
| Mar 31, 2024 | -3.04 Mn |
| Dec 31, 2023 | 2.41 Mn |
| Sep 30, 2023 | 2.22 Mn |
| Jun 30, 2023 | 2.03 Mn |
| Mar 31, 2023 | -1.28 Mn |
| Dec 31, 2022 | 1.29 Mn |
| Sep 30, 2022 | 928,000.00 |
| Jun 30, 2022 | 1.13 Mn |
| Mar 31, 2022 | -1.09 Mn |
| Dec 31, 2021 | -1.55 Mn |
| Sep 30, 2021 | -838,000.00 |
| Jun 30, 2021 | -981,000.00 |
| Mar 31, 2021 | -910,000.00 |